WallStSmart

Accendra Health Inc (ACH)vsCencora Inc. (COR)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Cencora Inc. generates 12470% more annual revenue ($332.77B vs $2.65B). COR leads profitability with a 0.8% profit margin vs -11.4%. COR appears more attractively valued with a PEG of 0.65. COR earns a higher WallStSmart Score of 62/100 (C+).

ACH

Hold

44

out of 100

Grade: D

Growth: 2.7Profit: 2.5Value: 7.7Quality: 4.5
Piotroski: 2/9Altman Z: 0.32

COR

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 6.0Value: 5.3Quality: 5.0
Piotroski: 4/9Altman Z: 4.36
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACHUndervalued (+69.2%)

Margin of Safety

+69.2%

Fair Value

$7.73

Current Price

$0.23

$7.50 discount

UndervaluedFair: $7.73Overvalued
CORSignificantly Overvalued (-70.4%)

Margin of Safety

-70.4%

Fair Value

$190.32

Current Price

$324.35

$134.03 premium

UndervaluedFair: $190.32Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACH2 strengths · Avg: 9.0/10
Debt/EquityHealth
-3.2310/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.708/10

Growing faster than its price suggests

COR5 strengths · Avg: 9.0/10
Return on EquityProfitability
86.0%10/10

Every $100 of equity generates 86 in profit

Altman Z-ScoreHealth
4.3610/10

Safe zone — low bankruptcy risk

Market CapQuality
$65.06B9/10

Large-cap with strong market position

PEG RatioValuation
0.658/10

Growing faster than its price suggests

Free Cash FlowQuality
$2.43B8/10

Generating 2.4B in free cash flow

Areas to Watch

ACH4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$18.07M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-198.4%2/10

ROE of -198.4% — below average capital efficiency

COR4 concerns · Avg: 3.0/10
P/E RatioValuation
25.3x4/10

Moderate valuation

Profit MarginProfitability
0.8%3/10

0.8% margin — thin

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Price/BookValuation
20.3x2/10

Trading at 20.3x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : ACH

The strongest argument for ACH centers on Debt/Equity, PEG Ratio. PEG of 0.70 suggests the stock is reasonably priced for its growth.

Bull Case : COR

The strongest argument for COR centers on Return on Equity, Altman Z-Score, Market Cap. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bear Case : ACH

The primary concerns for ACH are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : COR

The primary concerns for COR are P/E Ratio, Profit Margin, Operating Margin. Debt-to-equity of 3.84 is elevated, increasing financial risk. Thin 0.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

ACH profiles as a turnaround stock while COR is a value play — different risk/reward profiles.

ACH carries more volatility with a beta of 1.57 — expect wider price swings.

COR is growing revenue faster at 5.1% — sustainability is the question.

COR generates stronger free cash flow (2.4B), providing more financial flexibility.

Bottom Line

COR scores higher overall (62/100 vs 44/100). ACH offers better value entry with a 69.2% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accendra Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Aluminum Corporation of China Limited, manufactures and sells alumina, primary aluminum and energy products in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.

Cencora Inc.

HEALTHCARE · MEDICAL DISTRIBUTION · USA

CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.

Want to dig deeper into these stocks?